Ambien Boxed Warning: What the FDA Changed and Why

Ambien (zolpidem) has helped millions of people fall asleep, but since 2019 its label has carried the FDA’s most serious type of safety alert. If you take it, have been prescribed it, or are thinking about asking for it, you should understand exactly what the Ambien boxed warning says, what led to it, and what you can do to lower your risk.

This guide walks through the change in plain language: what the FDA required, the evidence behind the decision, what “complex sleep behaviors” actually look like, who should avoid the drug entirely, and how to talk to your prescriber about safer ways to manage insomnia. It is educational and does not replace advice from the clinician who knows your history.

The Short Version

In April 2019 the FDA required a boxed warning on zolpidem (Ambien, Ambien CR, Edluar, Intermezzo, Zolpimist), eszopiclone (Lunesta) and zaleplon (Sonata).
The warning covers complex sleep behaviors: sleepwalking, sleep driving and other activities done while not fully awake, often with no memory afterward.
The agency also added a contraindication: anyone who has had such an episode on one of these drugs should not take them again.
Episodes can happen after the very first dose, at the lowest recommended dose, and in people with no history of sleepwalking.
If an episode happens, stop the medicine and contact your prescriber.

What Is a Boxed Warning, and Why Does It Matter?

A boxed warning (sometimes called a “black box warning”) is the FDA’s strongest label alert for a prescription drug. It appears at the top of the prescribing information inside a bordered box. Regulators use it when a medicine carries a risk that is serious enough to change how doctors prescribe it or how patients use it.

A boxed warning does not mean a drug is banned, and it does not mean everyone who takes it will be harmed. It means the potential harm is severe enough that the label must say so first, before anything else. Many commonly used medicines, from certain antidepressants to some pain relievers, carry one.

For Ambien, the box is about something unusual: behavior you may not remember. That is what makes it easy to underestimate. A side effect you can feel, such as nausea, tends to get your attention. A side effect that happens while you are not fully conscious often goes unnoticed until someone else tells you about it, or until there is an injury.

What the Ambien Boxed Warning Actually Says

In everyday terms, the box tells prescribers and patients three things:

Complex sleep behaviors can occur. These include sleepwalking, sleep driving and doing other things while not fully awake.
Some of these events have caused serious injury, including death.
Stop the medicine immediately if an episode happens. The label instructs that the drug be discontinued after any complex sleep behavior.

Alongside the box, the FDA required a contraindication. In drug labeling, a contraindication is a flat “do not use” for a specific group. Here, that group is people who have previously experienced a complex sleep behavior after taking zolpidem, eszopiclone or zaleplon. Doctors are told not to prescribe these medicines to them.

You can read the agency’s announcement on the FDA’s page for the 2019 Drug Safety Communication on insomnia medicines.

How We Got Here: A Short Timeline

The 2019 box did not appear out of nowhere. Concerns about sleep medicines and next-day or nighttime behavior had been building for years.

Period	What happened
1990s–2000s	Zolpidem becomes one of the most prescribed sleep aids. Sleepwalking and sleep-driving reports appear and are added to the label as warnings.
2013	The FDA requires lower recommended zolpidem doses, especially for women, because blood levels the next morning could impair driving and alertness.
2019	After reviewing serious cases, the FDA adds a boxed warning and a contraindication for zolpidem, eszopiclone and zaleplon.
Today	The warnings remain on current labeling, and many clinical guidelines favor non-drug treatment first for chronic insomnia.

The important point: the risk of complex sleep behaviors was already described in the label before 2019. What changed was prominence and strength. The FDA concluded that the existing language was not enough to convey how serious the outcomes could be.

What the FDA Found: The Evidence Behind the Change

The agency’s decision rested on a review of reported cases. Over roughly 26 years, the FDA identified 66 cases of complex sleep behaviors linked to these three medicines that led to serious harm. Twenty of those cases were deaths. The remaining cases involved serious but non-fatal injuries.

The harms described in the reports were not abstract. They included:

Falls and burns
Near-drowning and drowning
Carbon monoxide poisoning
Hypothermia and exposure to extreme cold, in some cases leading to loss of a limb
Motor vehicle collisions where the person was driving while asleep or only partly awake
Apparent suicide in some reports

Most of the people in these reports, 61 of the 66, had been taking zolpidem. The FDA noted that this lines up with zolpidem being prescribed far more often than the other two drugs. The agency also stated that the behaviors appeared more common with these three medicines than with other prescription sleep drugs.

A Note on What These Numbers Do and Don’t Mean

Sixty-six cases sounds small next to the number of prescriptions written over a quarter century, and the FDA itself called the events rare. But two features of this data make the number less reassuring than it first appears. First, these were cases reported to the agency or published in the medical literature, and voluntary reporting almost always undercounts what actually happens. Second, many people have no memory of the behavior, so an episode can go unrecognized by the person who had it.

That is why regulators judged that “rare” and “serious” together justified the strongest label available.

Why Would a Sleeping Pill Cause This?

The honest answer is that nobody knows for certain. The FDA states that the underlying mechanisms are not completely understood.

What is understood is the basic pharmacology. Zolpidem, eszopiclone and zaleplon are often called “Z-drugs.” They work by enhancing the activity of GABA, the brain’s main calming signal, at a particular receptor subtype. That quiets brain activity and promotes sleep.

One leading idea is that the drug can push the brain into a mixed state, where parts of it are asleep and the parts that control movement, speech and routine behavior are still switched on. Sleep specialists describe sleepwalking in general as this kind of partial arousal. A sedative may deepen certain sleep stages while also making it harder to fully wake, which could make partial arousal more likely in vulnerable people. This is an explanation scientists offer, not a settled finding, so treat it as a working theory.

What Complex Sleep Behaviors Look Like

When people hear “sleepwalking,” they picture someone shuffling down a hallway. Reports tied to sleep medicines are often more elaborate, and that is precisely why they are dangerous. The person can appear awake and purposeful to onlookers while being unresponsive in terms of judgment and memory.

Examples described in FDA materials and clinical literature include:

Sleep driving: getting in a car and driving, sometimes for a long distance, with no recollection.
Sleep cooking and eating: preparing food, using a stove or oven, or eating unusual combinations of items. Unsafe use of a stove is one example the agency has cited.
Sleep conversations and phone use: making calls, sending texts or emails, or having conversations that the person cannot recall.
Leaving the home: walking outdoors, sometimes in cold weather and inappropriate clothing.
Other activities: cleaning, shopping online, or handling objects while not fully awake.

Signs You Might Have Had an Episode

Because memory is often missing, clues tend to show up afterward:

You wake to find food out, appliances on, or a mess in the kitchen you do not remember making.
A partner or housemate tells you that you were up, talking, or behaving oddly.
You find sent messages, purchases, or call logs you cannot explain.
Your car is in a different position, has less fuel, or has new damage.
You have unexplained bruises, cuts, or you wake up somewhere unusual.

Any of these while on a Z-drug deserves a conversation with your doctor, even if nothing bad came of it this time.

Who Should Not Take Ambien Under the New Rules?

The contraindication is the clearest rule in the update. Do not take zolpidem, and do not be prescribed it, if you have had a complex sleep behavior on any of the three affected medicines: zolpidem, eszopiclone or zaleplon. The prohibition crosses brands. If a sleepwalking or sleep-driving episode happened on Lunesta, switching to Ambien is not the answer, and vice versa.

People who deserve extra caution and a careful risk-benefit discussion include:

Anyone with a personal history of sleepwalking, night terrors or other parasomnias.
People who drink alcohol regularly or who might drink on a night they take the pill.
Those taking other sedating medicines, such as opioids, benzodiazepines, certain antihistamines, or some antidepressants and antipsychotics.
Older adults, who are more vulnerable to falls, confusion and next-day impairment.
People with sleep apnea, liver impairment, or a history of substance misuse.
Anyone who lives alone, since there may be nobody to notice or interrupt an episode.

Note the careful wording from regulators: these complex sleep behaviors can occur with and without a history of them, at the lowest recommended doses, and even after one dose. A clean history is not a guarantee, which is why the warning applies to everyone.

Practical Steps to Lower Your Risk if You Take Ambien

The boxed warning is not a reason to stop a prescribed medicine on your own, especially if you have been taking it regularly. Abruptly stopping can bring rebound insomnia and, for some people, withdrawal symptoms, so discuss any change with your prescriber first. If you do continue, these habits reduce risk.

Take it exactly as prescribed, and only at bedtime. Take it right before you get into bed, not earlier in the evening while you are still up and moving around.
Commit to a full night in bed. The label advises using it only when you can stay in bed for a full night, about seven to eight hours. If you must wake early, do not take it.
Never combine it with alcohol. Alcohol deepens sedation and impairs judgment. Sleep medicine and a nightcap is one of the riskiest pairings.
Review every other medicine you use. Ask your pharmacist about interactions with opioids, benzodiazepines, muscle relaxants, antihistamines and supplements that cause drowsiness.
Do not take extra doses. Do not re-dose in the middle of the night, and do not exceed what you were prescribed. Our article on Ambien uses explains what the medicine is meant for and how it is typically prescribed.
Make the home safer. Keep car keys out of reach, consider locking exterior doors, and remove easy access to the stove if you have had odd nighttime activity. Tell the people you live with what to watch for.
Be wary of the morning after. The FDA has warned that people can be impaired the next day even when they feel awake. Avoid driving or other tasks requiring full alertness if you feel any grogginess, particularly with extended-release forms.
Keep a simple sleep log. Note when you took the dose, how you slept, and anything odd. It helps your clinician judge whether the drug is worth continuing.

What to Do If You or Someone You Love Has an Episode

If a complex sleep behavior occurs, the direction on the label is straightforward: stop taking the medicine and contact your healthcare professional. Do this even if the episode seemed minor, funny, or harmless.

If anyone was hurt, or there was a car accident, fire, or other emergency, get immediate medical help.
Tell your prescriber exactly what happened, what dose you took, what else you had taken or drunk, and how long you had been using the medicine.
Do not simply switch to Lunesta or Sonata. Because of the contraindication, a different Z-drug is not a safe workaround.
Ask for the event to be documented in your medical record so that future prescribers see it.
Consider reporting it to the FDA through MedWatch. Patient reports help regulators spot patterns.

If you are a partner or family member who sees an episode in progress, avoid physically restraining the person unless they are in danger. Guide them calmly back to bed, make the environment safe, and tell them in the morning what you saw.

Did the Boxed Warning Change How Insomnia Is Treated?

The warning landed in a broader shift. For years, clinical guidance has recommended that chronic insomnia be treated first with cognitive behavioral therapy for insomnia (CBT-I), a structured, non-drug program, with medicines reserved for short-term or second-line use. The American College of Physicians has recommended CBT-I as the initial treatment for chronic insomnia in adults.

The Ambien box reinforces that sequence. If a medicine can occasionally cause a serious event and does not fix the underlying habits and thought patterns that sustain insomnia, it makes sense to try the approach that has no such risk first. We cover that route in detail in Can CBT-I Replace Ambien?

If You Are Weighing Different Sleep Medicines

Switching is not automatically safer. Other sleep medicines carry their own tradeoffs, including dependence risk, next-day sedation and interactions. If you are comparing options, these site guides may help you frame questions for your doctor:

Ambien vs Lunesta, which are both covered by the same boxed warning
Ambien vs Restoril, comparing a Z-drug with a benzodiazepine
Restoril vs Lunesta

Common Misunderstandings About the Warning

Because boxed warnings get reported in headlines, a few misconceptions have stuck around. Clearing them up helps you make calmer, better decisions.

“It only affects people who already sleepwalk.”

Not true. The FDA states that complex sleep behaviors happened in people with and without a history of them. A history of parasomnia is a reason for extra caution, but a clean history is not protection.

“If I feel fine in the morning, I was fine overnight.”

Feeling alert says little about what happened while you slept, because the defining feature of these episodes is missing memory. Likewise, the FDA has noted that people can be impaired the next morning even if they feel completely awake, so how you feel is an unreliable gauge for driving.

“Natural or over-the-counter sleep aids are automatically safer.”

Not necessarily. Many over-the-counter sleep products rely on sedating antihistamines, which cause their own problems such as next-day fogginess, dry mouth, urinary retention and confusion, particularly in older adults. “Natural” does not mean risk-free either, since supplements can interact with other medicines. Safer is a question to ask a pharmacist about your specific situation, not an assumption.

“The warning means my doctor made a mistake prescribing it.”

Prescribing zolpidem is still legal and, for some patients, reasonable. The box exists so that doctor and patient make the decision with full information, and so that anyone with a prior episode is steered away. A good prescriber will welcome your questions rather than treat them as a challenge.

“A different brand name means a different risk.”

Ambien, Ambien CR, Edluar, Intermezzo and Zolpimist all contain zolpidem and all fall under the warning. So do the generic zolpidem tablets from any manufacturer. Switching between brands or formulations of the same ingredient does not remove the risk.

Questions Worth Asking Your Prescriber

An appointment about sleep can feel rushed. Having specific questions ready makes the visit more useful:

Is a sleep medicine the right first step for me, or should we start with CBT-I or sleep-hygiene changes?
If I do take it, what is the lowest dose that is reasonable, and for how long?
Does anything else I take, including over-the-counter products or supplements, raise my risk?
Do I have a history of sleepwalking or parasomnias that should change the decision?
What should my household know about warning signs?
How and when will we plan to taper or stop?
Could something else, such as sleep apnea, depression, restless legs or pain, be driving my insomnia?

Frequently Asked Questions

Does the Ambien boxed warning mean Ambien is unsafe?

Not for everyone and not in every situation. It means a rare but serious risk exists and must be weighed against the benefit. For some people with short-term insomnia who follow the instructions, the balance may still favor treatment. For others, especially those with a history of parasomnia or heavy alcohol use, the balance may not.

Can sleepwalking happen the first time I take Ambien?

Yes. The FDA specifically notes that complex sleep behaviors can occur after the first dose as well as after longer use, and in people who have no history of them.

Does a lower dose protect me?

It can reduce next-morning impairment, which is why the FDA lowered recommended doses in 2013. But the agency states that complex sleep behaviors have occurred at the lowest recommended doses, so a low dose is not a guarantee.

Are Lunesta and Sonata safer than Ambien?

All three carry the same boxed warning and contraindication. Most reported cases involved zolpidem, but the FDA notes that this matches how widely zolpidem is prescribed, so it should not be read as proof that the others are safe.

Is it safe to drink alcohol with Ambien?

No. Alcohol and zolpidem both depress the central nervous system. Combined, they raise the risk of excessive sedation, impaired judgment and breathing problems. The FDA notes complex sleep behaviors can occur even without alcohol, so avoiding alcohol reduces but does not eliminate the risk.

If I had one episode, can I try again at a lower dose?

No. A prior complex sleep behavior on any of these drugs is the exact situation covered by the contraindication. Talk with your doctor about non-drug care or a different class of treatment.

Can I stop Ambien suddenly after reading this?

Do not make that change without guidance if you have been using it regularly. Stopping abruptly can cause rebound insomnia and other symptoms. If you have had a complex sleep behavior, the label instructs you to stop and contact your clinician, so call them promptly and ask how to do it safely.

How long is Ambien meant to be used?

Immediate-release zolpidem is labeled for short-term treatment of insomnia, typically a matter of days to a couple of weeks. Longer use should be a deliberate, reviewed decision with your prescriber.

Key Takeaways

The FDA added a boxed warning in 2019 because complex sleep behaviors on zolpidem, eszopiclone and zaleplon caused serious injuries and deaths.
Episodes can occur at the first dose and at low doses, and often leave no memory.
If you have ever had such an episode on one of these drugs, you should not take them again.
Take the medicine only at bedtime with a full night available, avoid alcohol and other sedatives, and make your home safer.
If an episode happens, stop the medicine and call your healthcare professional.
For long-lasting insomnia, CBT-I is the recommended first-line approach, and it carries none of these risks.

Sources and Further Reading

Medical disclaimer: This article is for general education and is not medical advice, diagnosis or treatment. Do not start, stop or change a medicine without talking to a licensed healthcare professional. If you or someone else is in danger or injured, call your local emergency number right away.